Generic Biosimilar Medicines Association

Making Medicines Affordable

Home
About GBMA
- Contact us
- GBMA Members
- Guiding principles
- Code of Practice
  - Code Complaint Committee
  - Historical Event Reporting
  - Annual Review
    - 2011
    - 2012
    - 2013
    - 2014
    - 2015
    - 2016
    - 2017
    - 2018
    - 2019
    - 2020
  - Lodging a complaint
- Media Enquiries
- Our Objectives
- Links
Advocacy
Generics
Biosimilars
Topics
News
- News 2021
- News 2020
- News 2019
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014
GBMA Education
COVID-19 Virus
- COVID-19 Virus: The Facts

You are here: Home / Biosimilars / GBMA Position on Biosimilars / Key Figures on Biosimilars

Key Figures on Biosimilars

ACCC helps to further protect Australians further protected against medicine shortages caused by COVID-19

December 12, 2021

10 December 2021 Canberra, ACT Canberra: Medicine shortages from the COVID-19 pandemic will continue … More...

GBMA welcomes a new member

December 7, 2021

Securing medicine supply and boosting biosimilar uptake a key focus for 2022 7 December … More...

Minister for Health & Ageing, the Hon Greg Hunt MP, applauded for two decades of public service

December 3, 2021

2 December 2021 Canberra, ACT Canberra: The peak body for … More…

© 2022 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us